continuous infusion

Type: Keyphrase
Name: continuous infusion
First reported Apr 21 2014 - Updated Apr 21 2014 - 1 reports

Thyroid HT did not improve neurodevelopment in premature infants

In infants born before 28 weeks of gestational age, neonatal thyroid hormone treatment did not appear to have an effect on neurodevelopment, according to study findings published in Thyroid .In the multicenter, phase 1 clinical trial, researchers evaluated ... [Published Orthopedics Today - Apr 21 2014]
First reported Apr 19 2014 - Updated Apr 19 2014 - 1 reports

Risk factors for nephrotoxicity caused by vancomycin continuous infusion

“Vancomycin-associated nephrotoxicity (VN) occurred in 26 of 155 (17%) patient episodes.” Norton et al (2014).Reference:Norton, K., Ingram, P.R., Heath, C.H. and Manning, L. (2014) Risk factors for nephrotoxicity in patients receiving outpatient continuous ... [Published IVTEAM - Apr 19 2014]
First reported Apr 18 2014 - Updated Apr 18 2014 - 1 reports

Special PP&P Buyer's Guide: Ambulatory Infusion Pumps

Ambulatory infusion pumps play an important role in delivering pain medications, TPNs, chemotherapy, and other infusions to patients in both inpatient and outpatient settings. Traditionally, the purchase of ambulatory infusion pumps has been left primarily ... [Published PPP Mag.com - Apr 18 2014]
First reported Apr 17 2014 - Updated Apr 17 2014 - 1 reports

Becton Dickinson : Patent Issued for Antimicrobial Coating Compositions

By a News Reporter-Staff News Editor at Drug Week -- Becton, Dickinson and Company ( Franklin Lakes, NJ ) has been issued patent number 8691887, according to news reporting originating out of Alexandria, Virginia , by NewsRx editors (see also Becton, ... [Published 4 Traders - Apr 17 2014]
First reported Apr 16 2014 - Updated Apr 16 2014 - 1 reports

GI Research Improving Quality of Life in Rectal, Colorectal Cancers

Image ToolsImproving quality of life, through more convenient treatment for patients with rectal cancer and by reducing unnecessary treatment for patients with advanced colorectal cancer, was the subject of two studies presented at the Gastrointestinal ... [Published Oncology Times - Apr 16 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 2 reports

BECTON DICKINSON : Patent Application Titled "Perpendicular Infusion Set and Disposable Inserter" Published Online

By a News Reporter-Staff News Editor at Politics & Government Week -- According to news reporting originating from Washington, D.C. , by VerticalNews journalists, a patent application by the inventors Bene, Eric ( Lynn, MA ); Cole, Russell ( New York, ... [Published 4 Traders - Apr 10 2014]
First reported Apr 10 2014 - Updated Apr 10 2014 - 1 reports

Phase II Study Finds Lower-Cost Mesothelioma Drug Safe and...

Mexican researchers say an alternative to the standard mesothelioma chemotherapy regimen can not only improve survival and quality of life, but can also save money. Scientists in the Thoracic Oncology Unit at Mexico’s National Cancer Institute say continuous ... [Published PRWeb - Apr 10 2014]
First reported Apr 01 2014 - Updated Apr 01 2014 - 1 reports

Hottest Links: The Blandness Of Q1, Blind Value, And Herbalife Refunds

Hottest links for Tuesday, April 1st, the late edition. Get our free daily newsletter and never miss a single linkfest . Also, now if you sign up you will get our new e-book on value investing.Top stories for today are posted below.  To your Tuesday afternoon ... [Published Value Walk - Apr 01 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Can MedTech Keep Up with Consumers’ Great Expectations?

Consumer medical technology is one of the broadest medical device sectors with the most opportunity. It holds the most demand and promise for newcomers and long-time players alike, but if medical device makers do not jump on this opportunity fully, the ... [Published Medical Design Technology - Mar 25 2014]
First reported Mar 25 2014 - Updated Mar 25 2014 - 1 reports

Half-molar sodium lactate infusion improves cardiac performance in acute heart failure: a pilot randomized controlled clinical trial

ResearchMarek Nalos , Xavier Maurice Leverve , Stephen Joseph Huang , Leonie Weisbrodt , Ray Parkin , Ian Mark Seppelt , Iris Ting and Anthony Stuart McleanCritical Care 2014, 18 :R48doi:10.1186/cc13793Published: 25 March 2014Abstract (provisional) ... [Published Critical Care - Mar 25 2014]
First reported Mar 24 2014 - Updated Mar 24 2014 - 1 reports

Portola Pharmaceuticals initiates Phase III bleeding study

Portola Pharmaceuticals, Inc., a biopharmaceutical company, has initiated a Phase III study of andexanet alfa, the company's investigational Factor Xa inhibitor reversal agent, in patients suffering from a major bleeding episode. The study will evaluate ... [Published Individual.com - Mar 24 2014]
First reported Mar 19 2014 - Updated Mar 19 2014 - 1 reports

Reports Outline Clinical Trials and Studies Study Results from GlaxoSmithKline

By a News Reporter-Staff News Editor at Clinical Trials Week -- Fresh data on Clinical Research are presented in a new report. According to news reporting originating from Philadelphia, Pennsylvania , by NewsRx correspondents, research stated, "Flavopiridol ... [Published 4 Traders - Mar 19 2014]

Quotes

From the background information supplied by the inventors, news correspondents obtained the following quote: "The present invention relates to antimicrobial compositions and methods for use of those compositions in various medical applications. One of the major challenges of modern medical treatment is control of infection and the spread of microbial organisms."
"FIG. 15 is a cross-sectional view of the infusion set of FIG. 12 taken along the line 15-15 of FIG. 12;"

More Content

All (31) | News (30) | Reports (0) | Blogs (1) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Thyroid HT did not improve neurodevelopment in ... [Published Orthopedics Today - Apr 21 2014]
Risk factors for nephrotoxicity caused by vanco... [Published IVTEAM - Apr 19 2014]
Safe IV Medication Use in Critically Ill Patients [Published PPP Mag.com - Apr 18 2014]
Special PP&P Buyer's Guide: Ambulatory Infusion... [Published PPP Mag.com - Apr 18 2014]
Becton Dickinson : Patent Issued for Antimicrob... [Published 4 Traders - Apr 17 2014]
GI Research Improving Quality of Life in Rectal... [Published Oncology Times - Apr 16 2014]
Lexicon Pharmaceuticals' CEO Discusses LX4211 P... [Published Seeking Alpha - Apr 14 2014]
BECTON DICKINSON : Patent Application Titled "P... [Published 4 Traders - Apr 10 2014]
BECTON DICKINSON : Patent Application Titled "I... [Published 4 Traders - Apr 10 2014]
Phase II Study Finds Lower-Cost Mesothelioma Dr... [Published PRWeb - Apr 10 2014]
Rethinking Strategies to Prevent Hypocalcemia [Published The Cattle Site - Apr 08 2014]
Hottest Links: The Blandness Of Q1, Blind Value... [Published Value Walk - Apr 01 2014]
Researchers Submit Patent Application, "Insulin... [Published 4 Traders - Mar 26 2014]
Novel Molecular Aspects of Ghrelin and Leptin i... [Published Sexual Development - Mar 25 2014]
Portola announces phase 3 study of Factor Xa in... [Published Orthopedics Today - Mar 25 2014]
Can MedTech Keep Up with Consumers’ Great Expec... [Published Medical Design Technology - Mar 25 2014]
Half-molar sodium lactate infusion improves car... [Published Critical Care - Mar 25 2014]
Portola Pharmaceuticals initiates Phase III ble... [Published Individual.com - Mar 24 2014]
Portola Pharmaceuticals starts Phase III trial ... [Published Pharmaceutical Business Review - Mar 20 2014]
Human medicines European public assessment repo... [Published European Medicines Agency - Mar 20 2014]
Overview of Adult Outpatient Cancer Pain Manage... [Published U.S.Pharmacist - Mar 19 2014]
Reports Outline Clinical Trials and Studies Stu... [Published 4 Traders - Mar 19 2014]
Human medicines European public assessment repo... [Published European Medicines Agency - Mar 19 2014]
Portola Pharmaceuticals Initiates Phase 3 Study... [Published Benzinga.com - Mar 19 2014]
Retirement offers emeritus faculty freedom, unc... [Published Brown Daily Herald - Mar 19 2014]
Hormone causes hypoglycaemia after bypass surgery [Published Bariatric News - Mar 18 2014]
Reducing Post-Op Pain In Kids After High-Risk S... [Published Scientific Blogging - Medicine - Dec 17 2013]
Portola reports additional positive results fro... [Published Pharmaceutical Business Review - Dec 10 2013]
Novo Nordisk, Roche Diabetes to make insulin pu... [Published PharmaBiz - Nov 25 2013]
Estrogen receptors and methods of use [Published PharmCast - Oct 24 2013]
1 2
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Reducing Post-Op Pain In Kids After High-Risk S... [Published Scientific Blogging - Medicine - Dec 17 2013]
A new technique will significantly decrease pain for children following high-risk urology surgeries, according to a paper in the Journal of Pediatric Urology. The research team evaluated continuous infusion of local anesthesia using the ON-Q pain relief ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.